<p>Luye Pharma Group Ltd. has completed the transfer of a 25% equity interest in its subsidiary, Nanjing Luye, to NJ Xinshi. Following the completion of the transaction on 19 January 2026, Nanjing Luye is now owned 75% by Luye Pharma Group and 25% by NJ Xinshi. The company stated that the partnership agreement and related transactions allow the Group to maintain control over the identity of Nanjing Luye’s partner, supporting continuity, governance stability, and alignment of strategic objectives. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260127-12001713), on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

603368

02186

Luye Pharma Completes Transfer of 25% Stake in Nanjing Luye to NJ Xinshi